Die Grenzen der Adipositastherapie

Die zunehmende Adipositasprävalenz ist ein weltweites Gesundheitsproblem. Konservative, medikamentöse und endoskopische Therapiestrategien sind dabei wenig erfolgreich und die bariatrische Chirurgie ist nur für einen kleinen Patientenkreis nutzbar.

Schlüsselwörter

Adipositas - bariatrische Chirurgie - Ernährung - Appetitregulation

• Literatur

• 1 WHO. WHO Global InfoBase. Global Comparable Estimates, Risk Factors etc. Im Internet: https://apps.who.int/infobase/ (Stand: 23.5.16)
• 2 Branca F, Nikogosian H, Lobstein T ed. The challenge of obesity in the WHO European Region and the strategies for response: summary. Im Internet: http://www.euro.who.int/en/publications/abstracts/challenge-of-obesity-in-the-who-european-region-and-the-strategies-for-response-the.-summary (Stand: 23.5.16)
• 3 Flegal KM, Kit BK, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82
• 4 Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine 2003; 348: 1625-1638
• 5 Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology and Metabolism 2004; 89: 2548-2556
• 6 Apovian CM, Aronne LJ, Bessesen DH et al. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism 2015; 100: 342-362
• 7 Bueter M, le Roux CW. Gastrointestinal hormones, energy balance and bariatric surgery. International Journal of Obesity 2011; 35: 35-S39
• 8 Suzuki K, Jayasena CN, Bloom SR. The Gut Hormones in Appetite Regulation. Journal of Obesity 2011; 2011: 1-10
• 9 Farooqi IS, Keogh JM, Yeo GSH et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. The New England Journal of Medicine 2003; 348: 1085-1095
• 10 Wabitsch M, Funcke JB, Lennerz B et al. Biologically Inactive Leptin and Early-Onset Extreme Obesity. The New England Journal of Medicine 2015; 372: 48-54
• 11 Speliotes EK, Willer CJ, Berndt SI et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics 2010; 42: 937-948
• 12 Sacks FM, Bray GA, Carey VJ et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. The New England Journal of Medicine 2009; 360: 859-873
• 13 Sumithran P, Prendergast LA, Delbridge E et al. Long-term persistence of hormonal adaptations to weight loss. The New England Journal of Medicine 2011; 365: 1597-1604
• 14 Fildes A, Charlton J, Rudisill C et al. Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records. Am J Public Health 2015; 105: e54-e59
• 15 Saltiel AR. New therapeutic approaches for the treatment of obesity. Sci Transl Med 2016; 8: 1-11
• 16 Christensen R, Kristensen PK, Bartels EM et al. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. The Lancet 2007; 370: 1706-1713
• 17 Pi-Sunyer X, Astrup A, Fujioka K et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. The New England Journal of Medicine 2015; 373: 11-22
• 18 Rodgers RJ, Tschöp MH, Wilding JPH. Anti-obesity drugs: past, present and future. Disease Models & Mechanisms 2012; 5: 621-626
• 19 Chen Z, Guo L, Zhang Y et al. Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. The Journal of Clinical Investigation 2014; 124: 3391-3406
• 20 Fernandes M, Atallah AN, Soares BGO et al. Intragastric balloon for obesity. Cochrane Database Syst Rev 2007; CD004931
• 21 Patel SRH, Hakim D, Mason J et al. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surgery for Obesity and Related Diseases 2013; 9: 482-484
• 22 Sullivan S, Stein R, Jonnalagadda S et al. Aspiration Therapy Leads to Weight Loss in Obese Subjects: A Pilot Study. Gastroenterology 2013; 145: 1245-1252
• 23 Bang CS, Baik GH, Shin IS et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. YMGE 2015; 81: 1141-1149
• 24 Deutsche Adipositas Gesellschaft. Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas“. AWMF-Register Nr. 050/001 2014. Im Internet: http://www.adipositas-gesellschaft.de/fileadmin/PDF/Leitlinien/S3_Adipositas_Praevention_Therapie_2014.pdf (Stand: 23.5.16)
• 25 Sandoval D. Bariatric surgeries: beyond restriction and malabsorption. International Journal of Obesity 2011; 35: 45-49
• 26 Golomb I, Ben David M, Glass A et al. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy. JAMA Surg 2015; 150: 1051-1057
• 27 Gloy VL, Briel M, Bhatt DL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934
• 28 Karmali S, Brar B, Shi X et al. Weight Recidivism Post-Bariatric Surgery: A Systematic Review. Obes Surg 2013; 23: 1922-1933
• 29 Bocca G, Corpeleijn E, Stolk RP et al. Results of a Multidisciplinary Treatment Program in 3-Year-Old to 5-Year-Old Overweight or Obese Children: A Randomized Controlled Clinical Trial. Arch Pediatr Adolesc Med 2012; 166: 1109-1115
• 30 Danielsson P, Kowalski J, Ekblom Ö et al. Response of Severely Obese Children and Adolescents to Behavioral Treatment. Arch Pediatr Adolesc Med 2012; 166: 1103-1108